All News
Innovating healthcare: Balancing experience, safety, and sustainability
Subramanian highlights the importance of balancing experience, safety, and sustainability in healthcare innovation
Read MoreTrump Administration Temporarily Mutes Federal Health Officials
Scientific meetings were canceled, and research data on the bird flu outbreak was delayed, amid confusion over the directive.
Read MoreSTAT+: RFK Jr., an investor in a CRISPR biotech, has raised alarms about the technology
RFK Jr.'s comments about the gene-editing technology raise a question about how he would regulate it as head of HHS.
Read MoreTrump administration’s abrupt cancellation of scientific meetings prompts confusion, concern
A flurry of scientific gatherings and panels across federal science agencies were canceled on Wednesday, at a time of heightened sensitivity about how the Trump administration will shift the agencies�
Read MoreChild mental health admissions to acute wards in England rise 65% in a decade
Hospital wards struggle to cope with rising cases of self-harm and eating disorders, the study warnsThe number of children admitted to acute hospital wards in England due to serious concerns over thei
Read MoreTrump executive orders threaten healthcare of millions of Americans
Orders repeal directives expanding healthcare access and options for lower-income and middle-class AmericansWithin his first 48 hours back in office, Trump has signed several executive orders that thr
Read MoreSTAT+: Senate Democrats preview vaccine arguments ahead of RFK Jr. hearings
Bernie Sanders has widely been viewed as a lawmaker who could potentially support RFK Jr.
Read MoreFDA Approves Treosulfan as Part of AML/MDS Conditioning Regimen
(MedPage Today) -- The FDA approved treosulfan (Grafapex) with fludarabine as a preparative regimen for allogeneic hematopoietic stem cell transplantation in patients ages 1 year and older with acute
Read MoreSTAT+: RFK Jr. to face key Senate committee hearing before end of the month
President Trump’s pick to lead HHS, Robert F. Kennedy Jr., will appear before the Senate Finance Committee on Jan.
Read More